Clinical Trial Update: Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy [Phase 2]

View source ↗

Summary

A Phase 2 study of SCD411 in adults with wet age-related macular degeneration, retinal vein occlusion, diabetic macular edema, or diabetic retinopathy is listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy
• Retinal Vein Occlusion
• Wet Age-related Macular Degeneration

Drugs mentioned

• SCD411 (SCD411)

Snippet

Sponsor: Sam Chun Dang Pharm. Co. Ltd. | Conditions: Neovascular (Wet) Age-Related Macular Degeneration, Retinal Vein Occlusion | Phase 2 | Status: NOT_YET_RECRUITING